These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10845277)

  • 1. RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters.
    Kahn HJ; Yang LY; Blondal J; Lickley L; Holloway C; Hanna W; Narod S; McCready DR; Seth A; Marks A
    Breast Cancer Res Treat; 2000 Mar; 60(2):143-51. PubMed ID: 10845277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of reverse-transcriptase polymerase chain reaction (RT-PCR) for carcinoembryonic antigen, cytokeratin 19, and maspin in the detection of tumor cells in leukapheresis products from patients with breast cancer: comparison with immunocytochemistry.
    López-Guerrero JA; Gilabert PB; González EB; Sanz Alonso MA; Pérez JP; Talens AS; Oraval EA; de la Rubia Comos J; Boix SB
    J Hematother; 1999 Feb; 8(1):53-61. PubMed ID: 10192302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative correlation of cytokeratin 19 mRNA level in peripheral blood with disease stage and metastasis in breast cancer patients: potential prognostic implications.
    Wong IH; Yeo W; Chan AT; Johnson PJ
    Int J Oncol; 2001 Mar; 18(3):633-8. PubMed ID: 11179498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine needle aspiration may shed breast cells into peripheral blood as determined by RT-PCR.
    Hu XC; Chow LW
    Oncology; 2000 Sep; 59(3):217-22. PubMed ID: 11053989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes.
    Schröder CP; Ruiters MHJ; de Jong S; Tiebosch ATMG; Wesseling J; Veenstra R; de Vries J; Hoekstra HJ; de Leij LFMH; de Vries EGE
    Int J Cancer; 2003 Sep; 106(4):611-618. PubMed ID: 12845661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.
    Stathopoulou A; Gizi A; Perraki M; Apostolaki S; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
    Clin Cancer Res; 2003 Nov; 9(14):5145-51. PubMed ID: 14613993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
    Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
    Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of occult bone marrow micrometastases of breast cancer detected by quantitative polymerase chain reaction for cytokeratin 19 mRNA.
    Ikeda N; Miyoshi Y; Motomura K; Inaji H; Koyama H; Noguchi S
    Jpn J Cancer Res; 2000 Sep; 91(9):918-24. PubMed ID: 11011120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of occult breast cancer cells by amplification of CK19 mRNA by reverse transcriptase-polymerase chain reaction: role of surgical manipulation.
    Galán M; Viñolas N; Colomer D; Soler G; Muñoz M; Longarón R; Ventura PJ; Gascón P; Estapé J
    Anticancer Res; 2002; 22(5):2877-84. PubMed ID: 12530011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of cytokeratin 19 mRNA and CYFRA 21-1 (cytokeratin 19 fragments) in blood of Tunisian women with breast cancer.
    Marrakchi R; Ouerhani S; Benammar S; Rouissi K; Bouhaha R; Bougatef K; Messai Y; Khadimallah I; Rahal K; Ben Ammar-Elgaaied A
    Int J Biol Markers; 2008; 23(4):238-43. PubMed ID: 19199272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low specificity of cytokeratin 19 mRNA expression in the peripheral blood cells from patients with ovarian tumors.
    Takano H; Okamoto A; Fukushima K; Ochiai K; Tanaka T
    Oncol Rep; 2000; 7(5):1023-5. PubMed ID: 10948333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: correlation with clinical stage of disease.
    Gradilone A; Gazzaniga P; Silvestri I; Gandini O; Trasatti L; Lauro S; Frati L; Aglianò AM
    Oncol Rep; 2003; 10(1):217-22. PubMed ID: 12469172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR.
    Park HS; Han HJ; Lee S; Kim GM; Park S; Choi YA; Lee JD; Kim GM; Sohn J; Kim SI
    Yonsei Med J; 2017 Jan; 58(1):19-26. PubMed ID: 27873491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance.
    Stathopoulou A; Vlachonikolis I; Mavroudis D; Perraki M; Kouroussis Ch; Apostolaki S; Malamos N; Kakolyris S; Kotsakis A; Xenidis N; Reppa D; Georgoulias V
    J Clin Oncol; 2002 Aug; 20(16):3404-12. PubMed ID: 12177100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK19, MUC1 and CEA using RT-PCR.
    Berois N; Varangot M; Aizen B; Estrugo R; Zarantonelli L; Fernández P; Krygier G; Simonet F; Barrios E; Musé I; Osinaga E
    Eur J Cancer; 2000 Apr; 36(6):717-23. PubMed ID: 10762743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) to detect breast carcinoma cells in peripheral blood.
    Aerts J; Wynendaele W; Paridaens R; Christiaens MR; van den Bogaert W; van Oosterom AT; Vandekerckhove F
    Ann Oncol; 2001 Jan; 12(1):39-46. PubMed ID: 11249047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction.
    Burchill SA; Bradbury MF; Pittman K; Southgate J; Smith B; Selby P
    Br J Cancer; 1995 Feb; 71(2):278-81. PubMed ID: 7530983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Levels of cytokeratin CK19 expression in mononuclear blood cells evaluated using a reverse PCR (RT-PCR)].
    López Guerrero JA; Bolufer P; Barragán E; Sanz Alonso M; Palau J; Sempere A; De la Rubia J; Bonanad S; Torregrosa MD
    Sangre (Barc); 1996 Dec; 41(6):441-6. PubMed ID: 9148421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative real-time RT-PCR detection for CEA, CK20 and CK19 mRNA in peripheral blood of colorectal cancer patients.
    Xu D; Li XF; Zheng S; Jiang WZ
    J Zhejiang Univ Sci B; 2006 Jun; 7(6):445-51. PubMed ID: 16691638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.